Market News & Trends
MBX Biosciences Announces US FDA Clearance of IND Application for the Treatment of Post-Bariatric Hypoglycemia
MBX Biosciences, Inc. recently announced the US FDA has cleared the Investigational New Drug (IND) application for MBX 1416, the company’s long-acting glucagon-like peptide 1…
Preclinical Data Shows Strong Immunogenicity & Protection With IMUNON’s PlaCCine DNA-Based Vaccines Modality
IMUNON, Inc. recently announced a manuscript titled Strong immunogenicity & protection in mice with PlaCCine: A COVID-19 DNA vaccine formulated with a functional polymer is available…
IGC Pharma Expands Phase 2 Trial of IGC-AD1 to Include the University of Puerto Rico
IGC Pharma, Inc. recently announced the addition of an important trial site at the University of Puerto Rico network as an expansion of the company’s…
Gerresheimer Expands Technical Competence Center in Wackersdorf
Gerresheimer is dedicating even more space to small batch production. It has expanded the capacity of its small-batch production (SBP) area in Wackersdorf by removing…
Sygnature Discovery Accelerates Global Growth With Major North American Acquisition
Leading integrated drug discovery partner, Sygnature Discovery, recently announced its acquisition of one of North America’s largest discovery Contract Research Organizations, Canada-based….
First Patient Enrolled in Investigator-Initiated Trial With OCS-01 Eye Drops for the Treatment of Cystoid Macular Edema
Oculis Holding AG recently announced the first patient has been enrolled in the investigator-initiated LEOPARD trial evaluating the potential of OCS-01 eye drops, Oculis’ novel…
KBio & ZERO Announce Exclusive Strategic Alliance to Develop a Globally Distributed & Rapidly Deployable Plant-Based Molecular Farming Network
KBio and ZERO recently announced an exclusive strategic alliance to build the world’s first transportable globally distributed plant-based molecular farming network to include therapeutic, pandemic…
ProQR Therapeutics & Laboratoires Théa Announce Agreement for Théa to Acquire ProQR’s Sepofarsen & Ultevursen Ophthalmic Assets
ProQR Therapeutics N.V. and Laboratoires Théa recently announced an agreement in which ProQR will divest its late-stage ophthalmic assets, sepofarsen and….
IntelGenx Completes Enrollment for BUENA Montelukast VersaFilm Phase 2a Clinical Trial in Patients With Mild-to-Moderate Alzheimer’s Disease
IntelGenx Corp. recently announced it has completed patient enrollment in the ongoing Montelukast VersaFilm Phase 2a (BUENA) clinical trial in patients with mild-to-moderate Alzheimer’s Disease…
SupplyOne Revolutionizes Medical & Pharmaceutical Packaging, Driving Down Costs & Enhancing Profitability
SupplyOne, Inc. highlights its innovative packaging solutions specifically designed to address the key challenges faced by medical device and pharmaceutical manufacturers. "Regulatory compliance, product protection,…
Ocean Biomedical, Inc. Celebrates 95% Lung Cancer Tumor Reduction Results on World Lung Cancer Day
On World Lung Cancer Day, Ocean Biomedical, Inc. is sharing details of its multi-pronged Lung Cancer Program built on novel immunotherapy discoveries by Scientific Co-founder Dr. Jack A. Elias. He and his team have revealed that Chitinase 3-like-1 (CHi3L1) is a master regulator that inhibits….
Avenue Therapeutics Announces High Potency & Full Efficacy in a Model of Generalized Seizures for its Novel GABA-A Receptor Potentiator Supporting Phase 2 Clinical Study
Avenue Therapeutics, Inc. recently announced BAER-101, the company’s potentially best-in-class selective GABA-A α2,3 positive allosteric modulator (PAM), significantly suppressed seizures in a translational animal model…
AltruBio Announces Positive Topline Data from Phase 1 Trial of Immune Checkpoint Enhancer for the Treatment of Ulcerative Colitis
AltruBio Inc. recently announced positive topline data from its Phase 1 trial evaluating the company’s subcutaneously administered immune checkpoint enhancer (ICE), ALTB-268 in healthy volunteers. “We…
Mitsubishi Gas Chemical Develops First-Ever, PFAS-Free Oxygen Absorber to Help the Industry Meet Emerging Global Regulations
In response to the growing legislation around per- and polyfluoroalkyl substances (PFAS), Mitsubishi Gas Chemical (MGC) has launched the first future-proof, eco-friendly packaging solution for the industry using a cleaner chemistry within record-breaking turnaround…..
BioNTech Completes Acquisition of InstaDeep
BioNTech SE recently announced the completion of the acquisition of InstaDeep Ltd., a leading global technology company in the field of artificial intelligence (AI) and…
Bora Pharmaceuticals Unveils Eye-Opening New Facility for Ophthalmic Manufacturing
Bora Pharmaceuticals recently announce the opening of a new state-of-the-art facility in Taoyuan City, Taiwan. Officially opened by Bora Pharmaceuticals CEO Bobby Sheng and President of….
PharmAla Files Patent for Novel MDXX Molecule PharmAla-1
PharmAla Biotech Holdings Inc. recently announced it has filed a patent on the composition of matter of PharmAla-1. The patent filing follows a year of preclinical…
First Wave BioPharma Announces Initial Topline Results From Phase 2 Trial Investigating Enhanced Adrulipase Formulation
First Wave BioPharma, Inc. recently announced it has received topline results from its Phase 2 SPAN clinical trial investigating an enhanced enteric microgranule delivery formulation of adrulipase for the treatment of exocrine pancreatic….
George Medicines Completes Recruitment of first Phase 3 Hypertension Trial Investigating Novel Single-Pill Triple Combination Candidate
George Medicines recently announced all patients have been enrolled in its Phase 3 active-controlled trial evaluating the efficacy and safety of GMRx2, the company’s….
Centogene Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort
CENTOGENE N.V. recently announced the publication of a landmark study titled At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over…
